NY-S6422-2025
New York · S 6422 · 2025
Provides that prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy maybe include the name of the dispensing practice instead of the prescriber; provides for notice to patients.
Pro-LGBTQ+Pending
- Bill key
- NY-S6422-2025
- State
- New York
- Session
- 2025
- Introduced
- Last recorded status
- introduced
- Citation (Bluebook)
- S. 6422, 2025–2026 Leg., Reg. Sess. (N.Y. 2025), https://www.nysenate.gov/legislation/bills/2025/S6422.
- Short citation
- N.Y. S. 6422.
- Topics
- Tags
Summary
Provides that prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes fo…
Sponsors
| Name | Party | Office | District | Role |
|---|---|---|---|---|
| Brad Hoylman-Sigal | Democratic | Senator | SD-047 | Primary sponsor |
| Jeremy Cooney | Democratic | Senator | SD-056 | Co-sponsor |
Bill text
- As introduced (2,946 characters)
Bill data and text from LegiScan (legiscan.com), licensed CC BY 4.0 and used in modified form. LegiScan does not endorse the Trans Data Initiative.
Sources and license
The title, last recorded status, sponsors and dates are from LegiScan (CC BY 4.0(opens another site), credit LegiScan). The side, status, summary, curator notes, tags, topics, law status, court note and citation are the team's own work (CC BY-NC 4.0(opens another site)).